390 views
0

WHY THIS MATTERS IN BRIEF

Today millions of people in the world, for a variety of reasons, have trouble moving their bodies, but new brain controlled exoskeletons could help them regain their movement and rehabilitate them at the same time.

 

People familiar with the Terminator series from the 1980’s and 1990’s will remember a little well-known company called Cyberdyne who stumbled upon some Terminator parts “from the future” and used them to create, well, a whole array of advanced robotics products in the present day. Now, a company of the same name in Japan, has just announced that it’s become the first robotics company to receive FDA approval for a new autonomous, brain controlled robotic human exoskeleton.

 

RELATED
Kurzweil: AI aces Turing Test in 2029, and the Singularity arrives in 2045

 

In today’s world the Cyberdyne Group is the company behind the “Cyberdyne HAL” which the company is calling “the world’s first robotic medical device,” and HAL, which is short for Hybrid Assistive Limb, is an exoskeleton that “enhances its users’ strength and stability.”

 

Watch HAL In Action

 

HAL’s basically, for want of a better description, a brain controlled exoskeleton for a person’s lower torso that uses a network of “stick on” sensors that are attached to a patients legs that can detect the faint bio-electric signals sent from the patient’s brain to the muscles in their legs, which then triggers the HAL exoskeleton to move in the desired way.

 

RELATED
New regenerative bandage heals wounds four times faster

 

HAL, which can be controlled both autonomously and manually, will now start taking its place in hospitals around the US to help rehabilitate patients who are unable to walk, and while it’s previously been marketed as a medical device within both Europe and Japan the FDA’s medical clearance in the US is now seen by many as validating the exoskeleton’s therapeutic effects, and as a consequence we can expect many more brain controlled Terminator inspired “robo” exoskeletons to follow its lead.

About author

Matthew Griffin

Matthew Griffin, described as “The Adviser behind the Advisers” and a “Young Kurzweil,” is the founder and CEO of the 311 Institute, a global futures and deep futures consultancy working between the dates of 2020 to 2070, and is an award winning futurist, and author of “Codex of the Future.” Regularly featured in the global media, including AP, BBC, CNBC, Discovery, RT, and Viacom, Matthew’s ability to identify, track, and explain the impacts of hundreds of revolutionary emerging technologies on global culture, industry and society, is unparalleled. Recognised for the past six years as one of the world’s foremost futurists, innovation and strategy experts Matthew is an international speaker who helps governments, investors, multi-nationals and regulators around the world envision, build and lead an inclusive, sustainable future. A rare talent Matthew’s recent work includes mentoring Lunar XPrize teams, re-envisioning global education and training with the G20, and helping the world’s largest organisations envision and ideate the future of their products and services, industries, and countries. Matthew's clients include three Prime Ministers and several governments, including the G7, Accenture, Bain & Co, BCG, BOA, Blackrock, Bentley, Credit Suisse, Dell EMC, Dentons, Deloitte, Du Pont, E&Y, GEMS, HPE, Huawei, JPMorgan Chase, KPMG, McKinsey, PWC, Qualcomm, SAP, Samsung, Sopra Steria, UBS, and many more.

Your email address will not be published. Required fields are marked *